NDF Research

Latest news and analysis on NDF Research

PolyNovo - CSIRO-developed technology hits the big time

PNV
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Bionomics' new drug that the world is likely to pay attention to

BNO
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Viralytics - The Steel City's valuable contribution to defeating cancer

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Mayne Pharma - Emerging world leader in generic drugs

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Nanosonics makes it into the black as our latest billion dollar Life Sciences success story

NAN
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Boom times for AFT Pharmaceuticals

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Monoclonal antibodies are a >US$70bn drug class. This Aussie company is set to revolutionise that market

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Clinuvel - Proof that Australian companies can do world-class drug development

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Medical Developments - the big money is still to come

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

The amazing comeback of Reva Medical (ASX: RVA)

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research
31-40 of 47
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now